On June 4, 2024, Daniel Spiegelman, Director at Myriad Genetics Inc (NASDAQ:MYGN), executed a sale of 7,576 shares of the company. The transaction was documented in a recent SEC Filing. Following this...
Source LinkOn June 4, 2024, Daniel Spiegelman, Director at Myriad Genetics Inc (NASDAQ:MYGN), executed a sale of 7,576 shares of the company. The transaction was documented in a recent SEC Filing. Following this...
Source Link
Comments